Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Estrogens and the endometrium].

Y Rochet

    Revue Francaise De Gynecologie Et D'Obstetrique
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Estrogen therapy may increase endometrial cancer risk, while combined estrogen-progestogen therapy might offer protection. Careful estrogen selection and progesterone co-administration are advised for menopausal hormone therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].

    Journal de gynecologie, obstetrique et biologie de la reproduction·1993
    Same author

    [Tubal sterility. What treatment to propose: IVF or surgery?].

    Revue francaise de gynecologie et d'obstetrique·1992
    Same author

    [Treatment of in situ ductal cancers of the breast].

    Revue francaise de gynecologie et d'obstetrique·1991
    Same author

    [Absence of peritonization after pelvic cancer surgery. Results in 157 cases].

    Journal de gynecologie, obstetrique et biologie de la reproduction·1991
    Same author

    [Endoscopic surgery in the surgery of cancer of the uterine cervix].

    Journal de gynecologie, obstetrique et biologie de la reproduction·1991
    Same author

    [Prolapse and urinary incontinence. Apropos of 275 cases].

    Revue francaise de gynecologie et d'obstetrique·1988
    Same journal

    Endometriomas; Operative diagnosis and treatment.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Endometriomas; Pathology and anatomy.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Pelvic endometriosis.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Uterine fibroid.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    Suppurative thrombophlebitis of the left utero-ovarian vein; penicillin; Surgical treatment by venous resection; healing.

    Revue francaise de gynecologie et d'obstetrique·2010
    Same journal

    The subtotal section of the uterine body in the fibroid.

    Revue francaise de gynecologie et d'obstetrique·2010
    See all related articles

    Area of Science:

    • Gynecology
    • Oncology
    • Endocrinology

    Context:

    • Growing concerns regarding the rise in endometrial cancer incidence among women undergoing estrogen therapy.
    • Retrospective studies suggest a link, but methodological limitations raise questions about causality.
    • Oestroprogestational hormone therapy shows potential protective effects against endometrial carcinoma.

    Purpose:

    • To critically evaluate the association between estrogen therapy and endometrial cancer.
    • To explore the role of combined oestroprogestational therapy in endometrial cancer prevention.
    • To provide guidance on hormone replacement therapy for menopausal women.

    Summary:

    • While some studies indicate an increased risk of endometrial cancer with estrogen use, these findings are often based on retrospective data with potential biases.

    Related Experiment Videos

  • Conversely, the use of combined estrogen and progestogen therapy appears to mitigate the risk of developing endometrial carcinoma.
  • The author recommends a cautious approach to estrogen therapy during menopause, emphasizing individualized treatment under medical supervision and the potential benefit of natural estrogens combined with progesterone.

    • Impact:

    • Informs clinical practice regarding the risks and benefits of different hormone therapy regimens for menopausal women.
    • Highlights the need for further rigorous research to clarify the complex relationship between hormone therapy and endometrial cancer.
    • Promotes personalized medicine in hormone replacement therapy, considering individual patient needs and risk factors.